An aye for eye gene therapy

被引：13

作者：

Bennett, J ^{[1
]}

机构：

[1] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA

来源：

HUMAN GENE THERAPY | 2006年 / 17卷 / 02期

关键词：

D O I：

10.1089/hum.2006.17.177

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：177 / 179

页数：3

共 25 条

[11] Gene therapy and retinitis pigmentosa: advances and future challenges [J].

Dejneka, NS ;

Bennett, J .

BIOESSAYS, 2001, 23 (07) :662-668

[12] PREVENTION OF PROGRAMMED CELL-DEATH OF SYMPATHETIC NEURONS BY THE BCL-2 PROTOONCOGENE [J].

GARCIA, I ;

MARTINOU, I ;

TSUJIMOTO, Y ;

MARTINOU, JC .

SCIENCE, 1992, 258 (5080) :302-304

[13] Pegaptanib for neovascular age-related macular degeneration [J].

Gragoudas, ES ;

Adamis, AP ;

Cunningham, ET ;

Feinsod, M ;

Guyer, DR .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2805-2816

[14]

Hoffman LM, 1997, INVEST OPHTH VIS SCI, V38, P2224

[15]

Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338

[16]

LEBHERZ C, 2006, UNPUB NOVEL AAV SERO

[17]

Leibowitz H M, 1980, Surv Ophthalmol, V24, P335

[18]

LI TS, 1994, INVEST OPHTH VIS SCI, V35, P2543

[19] Efficient gene transfer into retinal cells using adenoviral vectors:: Dependence on receptor expression [J].

Mallam, JN ;

Hurwitz, MY ;

Mahoney, T ;

Chévez-Barrios, P ;

Hurwitz, RL .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (06) :1680-1687

[20]

*NAT ADV EYE COUNC, 1993, VIS RES NAT PLAN 199

← 1 2 3 →